K. Papp, “Efficacy and Safety of Ruxolitinib Cream for the Treatment of Atopic Dermatitis: Results From Two Phase 3, Randomized, Double-Blind Studies”, J of Skin, vol. 4, no. 6, p. s95, Oct. 2020.